Effect of the mTOR Inhibitor Everolimus on Angiogenic Biomarkers in Patients with Skin Lesions and Subependymal Giant Cell Astrocytoma (SEGA) Associated with Tuberous Sclerosis Complex (TSC)

被引：0
|
作者：
Franz, D. N.
Frost, M. N.
Prestifilippo, J.
Brechenmacher, T.
Jozwiak, S.
机构：
来源：
ANNALS OF NEUROLOGY | 2013年 / 74卷
关键词：
Brain tumors/oncology; Genetics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [41] COST-CONSEQUENCE ANALYSIS (CCA) OF THE TREATMENT OF GROWING SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) SECONDARY TO TUBEROUS SCLEROSIS COMPLEX (TSC) IN BRAZIL
    Valentim, J.
    Stillman, I. O.
    Whalen, J. D.
    VALUE IN HEALTH, 2012, 15 (07) : A420 - A420
  • [42] Everolimus for Tumor Recurrence After Surgical Resection for Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex
    Franz, David Neal
    Agricola, Karen D.
    Tudor, Cynthia A.
    Krueger, Darcy A.
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (05) : 602 - 607
  • [43] Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma
    Song, Xue
    Said, Qayyim
    Tran, Oth
    Krueger, Darcy A.
    Bissler, John
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (06) : 1103 - 1110
  • [44] Everolimus for the Treatment of Renal Angiomyolipoma in Patients with Tuberous Sclerosis Complex Being Treated for Subependymal Giant Cell Astrocytoma
    Franz, David
    Belousova, Elena
    Frost, Michael
    Kuperman, Rachel
    Bebin, Martina
    Korf, Bruce
    Flamini, Robert
    Kohrman, Michael
    Sparagana, Steven
    Wu, Joyce
    Sahmoud, Tarek
    Shah, Gaurav
    Jozwiak, Sergiusz
    NEUROLOGY, 2012, 78
  • [45] Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma
    Gau, Shuo-Yan
    Chen, Sung-Lang
    Chang, Cheng-Siu
    Tsao, Teng-Fu
    Tsai, Jeng-Dau
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (10): : 1358 - 1362
  • [46] Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients
    Kotulska, Katarzyna
    Borkowska, Julita
    Roszkowski, Marcin
    Mandera, Marek
    Daszkiewicz, Pawel
    Drabik, Krzysztof
    Jurkiewicz, Elzbieta
    Larysz-Brysz, Magdalena
    Nowak, Katarzyna
    Grajkowska, Wieslawa
    Domanska-Pakiela, Dorota
    Jozwiak, Sergiusz
    PEDIATRIC NEUROLOGY, 2014, 50 (04) : 307 - 312
  • [47] A case of subependymal giant cell astrocytoma not associated with tuberous sclerosis
    Watanabe, Y
    Oki, S
    Migita, K
    Isobe, N
    Okazaki, T
    Nabika, S
    NEUROLOGICAL SURGERY, 2003, 31 (05): : 543 - 548
  • [48] Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study)
    Trelinska, Joanna
    Dachowska, Iwona
    Baranska, Dobromila
    Stawiski, Konrad
    Kotulska, Katarzyna
    Fendler, Wojciech
    Jozwiak, Sergiusz
    Mlynarski, Wojciech
    PEDIATRIC BLOOD & CANCER, 2017, 64 (06)
  • [49] Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis
    Sun, Peter
    Kohrman, Michael
    Liu, Jamae
    Guo, Amy
    Rogerio, Jaqueline
    Krueger, Darcy
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (04) : 657 - 663
  • [50] Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
    Jozwiak, Sergiusz
    Stein, Karen
    Kotulska, Katarzyna
    FUTURE ONCOLOGY, 2012, 8 (12) : 1515 - 1523
12345